Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants-Reference-Cited by-同舟云学术

Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants

Published:2021-03 Issue:3 Volume:96 Page:658-665
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Pastori Daniele^ORCID,Menichelli Danilo,Del Sole Francesco^ORCID,Pignatelli Pasquale^ORCID,Violi Francesco^ORCID,Casciaro Marco Antonio,Saliola Mirella,Carnevale Roberto,De Russis Marco

Funder

Sapienza Università di Roma

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur Heart J,2016

2. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet,2014

3. Outcomes of dabigatran and warfarin for atrial fibrillation in contemporary practice: a retrospective cohort study;Go;Ann Intern Med,2017

4. Atrial fibrillation and the risk of myocardial infarction;Soliman;JAMA Intern Med,2014

5. Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms;Violi;J Am Heart Assoc,2016

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness and Safety of Off-Label Underdosed Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis;Drug Safety;2024-08-30

2. Letter to the Editor: Features of clinical complexity in European patients with atrial fibrillation: A report from a European observational prospective AF registry;Current Problems in Cardiology;2024-06

3. Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry;European Journal of Internal Medicine;2024-01

4. Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry;Journal of Thrombosis and Thrombolysis;2023-08-11

5. Risk factor profile for newly diagnosed atrial fibrillation: 4‐year follow‐up of annual health examinations in a Japanese Adult Cohort;Journal of Arrhythmia;2023-06-15